Kim M. Whitten
Nessuna posizione attualmente
Profilo
Dr. Kim M.
Whitten is a Director-Clinical Development at Diffusion Pharmaceuticals LLC.
Dr. Whitten was previously employed as a Principal by AstraZeneca Canada, Inc., a Principal by GlaxoSmithKline, Inc., and a Principal by PPD Biomarker Discovery Sciences LLC.
She received her undergraduate degree from the University of South Carolina, an undergraduate degree from the University of Virginia, and a doctorate degree from the University of Kentucky.
Precedenti posizioni note di Kim M. Whitten
| Società | Posizione | Fine |
|---|---|---|
PPD Biomarker Discovery Sciences LLC
 PPD Biomarker Discovery Sciences LLC Miscellaneous Commercial ServicesCommercial Services Part of CellCarta Biosciences, Inc., PPD Biomarker Discovery Sciences LLC is a company that provides contract and consulting research and development services for the pharmaceutical and biotechnology industries. The company is based in San Diego, CA. PPD Biomarker Discovery Sciences was acquired by CellCarta Biosciences, Inc. from Pharmaceutical Product Development LLC on December 31, 2009 for $0.10 million. | Corporate Officer/Principal | - |
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Diffusion Pharmaceuticals LLC
 Diffusion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals LLC develops and manufactures pharmaceutical products. The firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia (oxygen deprivation) is known to diminish the effectiveness of current treatments. The company was founded by Matthew W. Hantzmon, John L. Gainer, and David G. Kalergis in February 2001 and is headquartered in Charlottesville, VA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Kim M. Whitten
| University of Kentucky | Doctorate Degree |
| University of South Carolina | Undergraduate Degree |
| University of Virginia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Diffusion Pharmaceuticals LLC
Diffusion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals LLC develops and manufactures pharmaceutical products. The firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia (oxygen deprivation) is known to diminish the effectiveness of current treatments. The company was founded by Matthew W. Hantzmon, John L. Gainer, and David G. Kalergis in February 2001 and is headquartered in Charlottesville, VA. | Health Technology |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
PPD Biomarker Discovery Sciences LLC
PPD Biomarker Discovery Sciences LLC Miscellaneous Commercial ServicesCommercial Services Part of CellCarta Biosciences, Inc., PPD Biomarker Discovery Sciences LLC is a company that provides contract and consulting research and development services for the pharmaceutical and biotechnology industries. The company is based in San Diego, CA. PPD Biomarker Discovery Sciences was acquired by CellCarta Biosciences, Inc. from Pharmaceutical Product Development LLC on December 31, 2009 for $0.10 million. | Commercial Services |
- Borsa valori
- Insiders
- Kim M. Whitten
